Mitsubishi Chemical to sell pharma unit to Bain Capital for $3.36 billion By Investing.com
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 07 2025
0mins
Should l Buy ?
Source: Investing.com
Mitsubishi Chemical's Sale: Mitsubishi Chemical has agreed to sell its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, to Bain Capital for approximately $3.36 billion as part of its strategy to streamline its portfolio.
Background on Tanabe Mitsubishi Pharma: The subsidiary was established last year with the aim of creating synergies within the group before being sold to the Boston-based private equity firm.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
